Gallium 68 P15 041

Drug Profile

Gallium 68 P15 041

Alternative Names: [68Ga]P15-041

Latest Information Update: 05 Aug 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Five Eleven Pharma
  • Class Radiopharmaceutical diagnostics
  • Mechanism of Action Emission-computed tomography enhancers; Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase 0 Bone metastases

Most Recent Events

  • 25 Jul 2016 Phase-0 for Bone metastases (Diagnosis) in USA (Parenteral) (NCT02826382)
  • 19 Jul 2016 Five Eleven Pharma plans a phase 0 trial in Bone metastases (Diagnosis) in USA (NCT02826382)
  • 01 Jul 2016 Preclinical trials in Bone metastases (Diagnosis) in USA (Parenteral) before July 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top